Evidence map›Paper›PMID 38967904›Full record

ReviewMolecular neurobiology2025

From Gut Microbiomes to Infectious Pathogens: Neurological Disease Game Changers.

Muhasina K M, Puja Ghosh, Krishnaveni Nagappan, Dhanabal S Palaniswamy, Rahima Begum, Md Rabiul Islam, Priti Tagde, Nusrat K Shaikh, Farha Farahim, Tonmoy Kumar Mondal

Abstract readReview
PubMed Publisher
In one paragraph

Review in Molecular neurobiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Muhasina K MDepartment of Pharmacognosy, JSS College of Pharmacy, Ooty, Tamil Nadu, 643001, India. km.muhasina@gmail.com.
Puja GhoshDepartment of Pharmacognosy, JSS College of Pharmacy, Ooty, Tamil Nadu, 643001, India.
Krishnaveni NagappanDepartment of Pharmaceutical Analysis, JSS College of Pharmacy, Ooty, Tamil Nadu, 643001, India.
Dhanabal S PalaniswamyDepartment of Pharmacognosy, JSS College of Pharmacy, Ooty, Tamil Nadu, 643001, India. spdhanabal@jssuni.edu.in.
Rahima BegumDepartment of Microbiology, Gono Bishwabidyalay, Dhaka, Bangladesh.
Md Rabiul IslamTennessee State University Chemistry department 3500 John A Merritt Blvd, Nashville, TN, 37209, USA.
Priti TagdePRISAL(Pharmaceutical Royal International Society), Branch Office Bhopal, Bhopal, Madhya Pradesh, 462042, India.
Nusrat K ShaikhDepartment of Quality Assurance, Smt. N. M, Padalia Pharmacy College, Navapura, Ahmedabad, 382 210, Gujarat, India.
Farha FarahimDepartment of Nursing, King Khalid University, Abha, 61413, Kingdom of Saudi Arabia.
Tonmoy Kumar MondalDepartment of Pharmacy, North South University, Dhaka, Bangladesh.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gut microbiota and infectious diseases affect neurological disorders, brain development, and function. Compounds generated in the gastrointestinal system by gut microbiota and infectious pathogens may mediate gut-brain interactions, which may circulate throughout the body and spread to numerous organs, including the brain. Studies shown that gut bacteria and disease-causing organisms may pass molecular signals to the brain, affecting neurological function, neurodevelopment, and neurodegenerative diseases. This article discusses microorganism-producing metabolites with neuromodulator activity, signaling routes from microbial flora to the brain, and the potential direct effects of gut bacteria and infectious pathogens on brain cells. The review also considered the neurological aspects of infectious diseases. The infectious diseases affecting neurological functions and the disease modifications have been discussed thoroughly. Recent discoveries and unique insights in this perspective need further validation. Research on the complex molecular interactions between gut bacteria, infectious pathogens, and the CNS provides valuable insights into the pathogenesis of neurodegenerative, behavioral, and psychiatric illnesses. This study may provide insights into advanced drug discovery processes for neurological disorders by considering the influence of microbial communities inside the human body.

Indexed as

Communicable DiseasesGastrointestinal MicrobiomeNervous System DiseasesAnimalsBrainHumansDrug discoveryGut microbiomesInfectious pathogensNeurological diseasePsychiatric illness

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.